Bausch Health Companies (BHC) Receivables (2009 - 2026)
Bausch Health Companies (BHC) posted Receivables of $2.3 billion for Q2 2026, up 3.29% sequentially from $2.2 billion in Q1 2026, and up 2.4% YoY from $2.2 billion in Q2 2025.
Bausch Health Companies (BHC) Receivables (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Receivables for 18 years, with the latest figure at $2.3 billion in Q2 2026.
- Quarterly Receivables rose 2.4% year-over-year to $2.3 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.3 billion (up 2.4% YoY) and the FY2025 annual result came in at $2.4 billion, up 9.86% from the prior year.
- Receivables grew to $2.3 billion in Q2 2026 per BHC's latest filing, from $2.2 billion in the prior quarter.
- Over five years, Receivables peaked at $2.4 billion in Q3 2025 and troughed at $144.0 million in Q4 2024.
- A 5-year average of $1.9 billion and a median of $2.0 billion in 2023 frame the typical range for Receivables.
- The sharpest annual moves came in 2024 and 2025: Receivables sank 92.79% in 2024, then jumped 1532.64% in 2025.
- Over 5 years, Receivables stood at $1.8 billion in 2022, then climbed by 11.62% to $2.0 billion in 2023, then tumbled by 92.79% to $144.0 million in 2024, then surged by 1532.64% to $2.4 billion in 2025, then fell by 3.74% to $2.3 billion in 2026.
- According to Business Quant data, Receivables over the past three periods registered $2.3 billion, $2.2 billion, and $2.4 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.29 Bn | 43.33 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 43.57 Bn | 39.92 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 32.09 Bn | 30.41 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.32 Bn | 19.66 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.99 Bn | 11.46 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.08 Bn | 9.91 Bn | - | 1.08 Bn |
| 10 | Bausch Health Companies | 2.55 Bn | 712.00 Mn | 2.10 Bn | 2.26 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.26 Bn |
| Mar 31, 2026 | 2.19 Bn |
| Dec 31, 2025 | 2.35 Bn |
| Sep 30, 2025 | 2.42 Bn |
| Jun 30, 2025 | 2.21 Bn |
| Mar 31, 2025 | 2.07 Bn |
| Dec 31, 2024 | 144.00 Mn |
| Sep 30, 2024 | 2.09 Bn |
| Jun 30, 2024 | 2.10 Bn |
| Mar 31, 2024 | 2.05 Bn |
| Dec 31, 2023 | 2.00 Bn |
| Sep 30, 2023 | 1.95 Bn |
| Jun 30, 2023 | 1.74 Bn |
| Mar 31, 2023 | 1.69 Bn |
| Dec 31, 2022 | 1.79 Bn |
| Sep 30, 2022 | 1.74 Bn |
| Jun 30, 2022 | 1.65 Bn |
| Mar 31, 2022 | 1.57 Bn |
| Dec 31, 2021 | 1.78 Bn |
| Sep 30, 2021 | 1.73 Bn |